The post MIND Matters | Quarterly Newsletter | Fall 2024 appeared first on UCI MIND.
Read More
An article in the New York Times is the latest to highlight the safety risks associated with recently approved new treatments for Alzheimer’s disease, lecanemab and donanemab. Being a carrier…
Read More
Message from the Director Dear Friends of UCI MIND, This summer, we lost our founder, Dr. Carl Cotman. Under Dr. Cotman’s leadership, UCI became an independent ADRC in 2000. He…
Read More
Breaking the Tyranny of Treatment: A New Perspective on Alzheimer’s Care The post Dr. Joshua Grill and colleague from Penn publish essay on clinical implications of new drugs appeared first…
Read More
This Hispanic Heritage Month, we proudly recognize the invaluable contributions of our faculty, staff, community partners, and supporters who are dedicated to addressing Alzheimer’s disease and related dementias in the…
Read More
AlzForum, the popular online publication for Alzheimer’s researchers, published a summary of recent advances from the MODEL-AD teams and highlighted the work of the principal investigators at UCI, Drs. Kim…
Read More
The New York Times recently covered a remarkable study published in the New England Journal of Medicine. The study performed clinical and imaging assessments of 353 adults deemed to be…
Read More
A recent article in the New York Times, How Poor Sleep Affects Your Risk of Dementia, summarizes some recent findings showing both excessively short and long sleep, as well as…
Read More